198 related articles for article (PubMed ID: 38115234)
21. Trabectedin for Advanced Soft Tissue Sarcoma: Ten Year Real-Life Perspective.
Shamai S; Merimsky O
Isr Med Assoc J; 2018 Oct; 20(10):599-603. PubMed ID: 30324774
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness analysis of pazopanib in second-line treatment of advanced soft tissue sarcoma in Spain.
Villa G; Hernández-Pastor LJ; Guix M; Lavernia J; Cuesta M
Clin Transl Oncol; 2015 Jan; 17(1):24-33. PubMed ID: 24981588
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma.
Kawai A; Araki N; Naito Y; Ozaki T; Sugiura H; Yazawa Y; Morioka H; Matsumine A; Saito K; Asami S; Isu K
Jpn J Clin Oncol; 2017 Feb; 47(2):137-144. PubMed ID: 28173193
[TBL] [Abstract][Full Text] [Related]
24. Analysis of clinical factors associated with survival in patients with soft-tissue sarcoma receiving trabectedin.
Simetić L; Blažičević K; Ladenhauser T; Golčić M; Majnarić T; Herceg D
Anticancer Drugs; 2021 Nov; 32(10):1058-1066. PubMed ID: 34232944
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of trabectedin for patients with unresectable and relapsed soft-tissue sarcoma in Japan: A Japanese Musculoskeletal Oncology Group study.
Kobayashi H; Iwata S; Wakamatsu T; Hayakawa K; Yonemoto T; Wasa J; Oka H; Ueda T; Tanaka S
Cancer; 2020 Mar; 126(6):1253-1263. PubMed ID: 31825533
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review.
Sharma S; Takyar S; Manson SC; Powell S; Penel N
BMC Cancer; 2013 Aug; 13():385. PubMed ID: 23937858
[TBL] [Abstract][Full Text] [Related]
27. [Histology-Specific Chemotherapy in Soft-Tissue Sarcomas].
Kobayashi E; Kawai A
Gan To Kagaku Ryoho; 2017 Jun; 44(6):468-472. PubMed ID: 28698435
[TBL] [Abstract][Full Text] [Related]
28. Eribulin Regresses a Doxorubicin-resistant Dedifferentiated Liposarcoma in a Patient-derived Orthotopic Xenograft Mouse Model.
Igarashi K; Kawaguchi K; Kiyuna T; Miyake K; Higuchi T; Yamamoto N; Hayashi K; Kimura H; Miwa S; Singh SR; Tsuchiya H; Hoffman RM
Cancer Genomics Proteomics; 2020; 17(4):351-358. PubMed ID: 32576580
[TBL] [Abstract][Full Text] [Related]
29. Pre-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Predictive Marker of Pazopanib Treatment for Soft-Tissue Sarcoma.
Sato Y; Nakano K; Wang X; Fukuda N; Urasaki T; Ohmoto A; Hayashi N; Yunokawa M; Ono M; Tomomatsu J; Saito M; Minami Y; Hayakawa K; Funauchi Y; Tanizawa T; Ae K; Matsumoto S; Takahashi S
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944888
[TBL] [Abstract][Full Text] [Related]
30. Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.
De Vita A; Recine F; Mercatali L; Miserocchi G; Spadazzi C; Liverani C; Bongiovanni A; Pieri F; Casadei R; Riva N; Fausti V; Amadori D; Ibrahim T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29292724
[TBL] [Abstract][Full Text] [Related]
31. Trabectedin use in soft-tissue sarcoma patients in a real-world setting: Data from an Italian national drug-access registry.
Vincenzi B; Napolitano A; Comandone A; Sanfilippo R; Celant S; Olimpieri PP; Di Segni S; Russo P; Casali PG
Int J Cancer; 2023 Feb; 152(4):761-768. PubMed ID: 36196483
[TBL] [Abstract][Full Text] [Related]
32. The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study.
Nakamura T; Tsukushi S; Asanuma K; Katagiri H; Ikuta K; Nagano A; Kozawa E; Yamada S; Shido Y; Yamada K; Kawanami K; Ishimura D; Sudo A; Nishida Y
Clin Exp Metastasis; 2019 Aug; 36(4):343-350. PubMed ID: 31209624
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis of pazopanib and trabectedin effectiveness in previously treated metastatic synovial sarcoma (second-line setting and beyond).
Carroll C; Patel N; Gunsoy NB; Stirnadel-Farrant HA; Pokras S
Future Oncol; 2022 Oct; 18(32):3651-3665. PubMed ID: 36399116
[TBL] [Abstract][Full Text] [Related]
34. Eribulin in advanced liposarcoma and leiomyosarcoma.
Setola E; Noujaim J; Benson C; Chawla S; Palmerini E; Jones RL
Expert Rev Anticancer Ther; 2017 Aug; 17(8):717-723. PubMed ID: 28621163
[TBL] [Abstract][Full Text] [Related]
35. The Role of Trabectedin in Soft Tissue Sarcoma.
Nakamura T; Sudo A
Front Pharmacol; 2022; 13():777872. PubMed ID: 35281940
[No Abstract] [Full Text] [Related]
36. The importance of treating by histological subtype in advanced soft tissue sarcoma.
Martín Broto J; Le Cesne A; Reichardt P
Future Oncol; 2017 Jan; 13(1s):23-31. PubMed ID: 27918201
[TBL] [Abstract][Full Text] [Related]
37. Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells.
Loi M; Salvatore G; Aquilano M; Greto D; Talamonti C; Salvestrini V; Melica ME; Valzano M; Francolini G; Sottili M; Santini C; Becherini C; Campanacci DA; Mangoni M; Livi L
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430780
[TBL] [Abstract][Full Text] [Related]
38. Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?
Shimada E; Endo M; Matsumoto Y; Tsuchihashi K; Ito M; Kusaba H; Nabeshima A; Nawata T; Maekawa A; Matsunobu T; Setsu N; Fujiwara T; Iida K; Nakagawa M; Hirose T; Kanahori M; Oyama R; Isobe T; Ariyama H; Kohashi K; Yamamoto H; Oda Y; Iwamoto Y; Akashi K; Baba E; Nakashima Y
J Clin Med; 2021 Oct; 10(21):. PubMed ID: 34768491
[TBL] [Abstract][Full Text] [Related]
39. Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma.
de Sande González LM; Martin-Broto J; Kasper B; Blay JY; Le Cesne A
Expert Rev Anticancer Ther; 2020 Nov; 20(11):957-963. PubMed ID: 32930637
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Targets for Bone and Soft-Tissue Sarcomas.
Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tsuchiya H
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30621224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
